NYSE: OSCR Oscar Health, Inc. 8-K

Oscar Health shareholders approve director slate, executive pay, and auditor at annual meeting

Filed June 9, 2026 · Period ending June 4, 2026 · ~1 min read

Key Changes

  • low

    All eight director nominees elected to one-year terms through 2027, including CEO Mario Schlosser and Chairman Mark Bertolini, each receiving over 750 million votes in favor with minimal opposition.

  • low

    Executive compensation approved in advisory vote with 98.9% support (765M for vs 8.9M against), signaling strong shareholder backing of management pay practices.

  • low

    PricewaterhouseCoopers ratified as 2026 auditor with 99.9% approval, maintaining continuity in external financial oversight.

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade OSCR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 9, 2026 8:37 PM